Research Paper Volume 14, Issue 19 pp 7866—7876
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
Figure 2. DTYMK RNA and protein expression in LUAD. (A) DTYMK mRNA expression levels in 535 lung cancer patients and matched adjacent normal samples. (B) Relative DTYMK expression in 54 paired lung cancer and noncancerous tissues. (C) DTYMK protein expression level based on CPTAC. (D) DTYMK protein levels based on Human Protein Atlas. ***P < 0.001.